A Peek Into The Market Before The Trading Starts
Pre-open movers US stock futures are mixed this morning, as investors are awaiting ISM manufacturing data. Futures for the Dow Jones Industrial Average gained 7 points to 13,162.00 and S&P 500 index futures rose 0.30 points to 1,393.90. Nasdaq 100 futures declined 1.25 points to 2,718.00.
A Peek Into Global Markets European markets were mixed today. The STOXX Europe 600 Index declined 0.02%, London's FTSE 100 Index moved up 0.32%.
Asian markets ended mixed, with Japan's Nikkei Stock Average dropping 1.78% and Australia's S&P/ASX 200 moving up 0.67%.
Broker Recommendation Analysts at UBS upgraded Abercrombie & Fitch Co (NYSE: ANF) from “neutral” to “buy.” The target price for Abercrombie & Fitch has been raised from $51 to $66.
Abercrombie & Fitch shares gained 2.65% to $51.50 in pre-market trading.
- Conn's, Inc. (NASDAQ: CONN) today announced that a subsidiary issued $103.7 million of BBBsf-rated, fixed-rate notes to provide additional liquidity and support for the Company's growth plans. To read the full news, click here.
- Teleflex Incorporated (NYSE: TFX) announced it has acquired the EZ-BlockerTM disposable catheter product line with a unique bifurcated distal end, a novel and patented bronchial blocker for lung isolation and one-lung ventilation. To read the full news, click here.
- National Health Investors Inc (NYSE: NHI) announced today it has entered into an amended $320 million unsecured credit facility that includes $120 million of combined 5-year and 7-year term loans that were drawn immediately at closing to pay down revolving credit borrowings and for other corporate purposes. To read the full news, click here.
- Imperial Sugar Company (NASDAQ: IPSU) and Louis Dreyfus Commodities LLC today announced a definitive agreement under which a subsidiary of Louis Dreyfus Commodities LLC will acquire Imperial Sugar through a cash tender offer and second step merger at $6.35 per share. To read the full news, click here.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.